Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study)

Am J Cardiol. 2002 Jun 15;89(12):1429-31. doi: 10.1016/s0002-9149(02)02362-7.

Authors

Michael R Tamberella¹, Deepak L Bhatt, Derek P Chew, Dean J Kereiakes, Eric J Topol, Steven R Steinhubl; GOLD Investigators

Affiliation

¹ Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA., USA

PMID: 12062743
DOI: 10.1016/s0002-9149(02)02362-7

No abstract available

MeSH terms

Angioplasty, Balloon, Coronary
Blood Platelets / drug effects
Blood Platelets / physiology
Female
Heart Diseases / prevention & control*
Hemorrhage / etiology*
Hemorrhage / prevention & control*
Humans
Male
Platelet Aggregation / drug effects
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / therapeutic use*
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
Prospective Studies

Substances

Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex